Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 trial

Medical and Pediatric Oncology

Volumn 30, Issue 5, 1998, Pages 269-275

  Klingebiel, T ^a   Pertl, U ^a   Hess, C F ^a   Jurgens, H ^a   Koscielniak, E ^a   Potter, R ^a   van Heek Romanowski, R ^a   Rossi, R ^a   Schott, C ^a   Spaar, H J ^a   Willnow, U ^a   Treuner, J ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Chemotherapy; Radiotherapy; Relapse treatment; Soft tissue sarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; NEUROECTODERM TUMOR; PRIORITY JOURNAL; RELAPSE; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; GERMANY; HUMANS; HYPERTHERMIA, INDUCED; IFOSFAMIDE; MALE; NEUROECTODERMAL TUMORS; PROSPECTIVE STUDIES; RECURRENCE; RHABDOMYOSARCOMA; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031949110     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199805)30:5<269::AID-MPO2>3.0.CO;2-D     Document Type: Conference Paper

References (15)